The concept that impaired insulin signalling influences neurodegenerative mechanisms in Alzheimer's disease (AD) and leads to impairment in cognitive processes is attracting increasing attention. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.